[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100464285":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":26,"locations":36,"responsibleParty":54,"collaborators":56,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":68,"enrollmentInfo":69,"targetDuration":25,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":39,"whyStopped":25,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Ramsay Générale de Santé","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"TD2 standard","ACTIVE_COMPARATOR","Standard TD2 follow-up",[13],"Behavioral: Study nurse intervention",{"label":15,"type":16,"description":17,"interventionNames":18},"TD2+ study Nurse","EXPERIMENTAL","Specific study nurse follow-up every 4 months in addition of standard FU.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Study nurse intervention","Contact everay 4 months with a dedicated study nurse",[9,15],null,[27,32],{"name":28,"role":29,"phone":30,"phoneExt":25,"email":31},"JF OUDET","CONTACT","068346567","jf.oudet@ecten.eu",{"name":33,"role":29,"phone":34,"phoneExt":25,"email":35},"MH BArba","0664888704","MH.Barba@ecten.eu",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Clinique Aguiléra","RECRUITING","Biarritz","Aquitaine","64200","France","FR",{"type":46,"coordinates":47},"Point",[48,49],-1.55684,43.48055,{"lat":49,"lon":48},[52],{"name":53,"role":29,"phone":25,"phoneExt":25,"email":25},"Aurélie LIETAER, DR",{"type":55,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[57],{"name":58,"class":6},"European Clinical Trial Experts Network","100464285","assessment-of-personalized-follow-up-in-prevention-of-type-2-diabetes-100464285",false,"NCT05325710","Assessment of Personalized Follow-up in Prevention of Type 2 Diabetes","Proxipart","Inclusion Criteria:\n\n* Patient, male or female, over the age of 18\n* Patient with a FINDRISC score ≥10 points\n* Beneficiary of a French health insurance system\n* Patient having been informed and having given their consent free, enlightened and written\n\nExclusion Criteria:\n\n* Patient over 75 years old\n* Patient already diagnosed with type 2 diabetes\n* Patient whose physical and\u002For psychological health is severely impaired, which according to the investigator may affect the compliance of the study participant.\n* Patient participating in another research\n* Patient in period of exclusion from another research always in progress at the time of inclusion.\n* Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by court order or administration.\n* Pregnant, breastfeeding or parturient women.\n* Patient hospitalized without consent","ALL","18 Years","75 Years",{"count":70,"type":71},230,"ESTIMATED","INTERVENTIONAL",[74],"NA","In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type 2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly underestimated,since it does not take into account people who are untreated or not diagnosed. However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed. Conclusions presented during the annual meeting of the european Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be present up to 20 years before the diagnosis.\n\nThe Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a diet too rich for a too sedentary daily life.\n\nFrom a medico-economic point of view, chronic pathologies (including diabetes) account for 60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20 million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros.\n\nThis study is part of this context as the starting point a reflection on a different, coordinated management, to know a preventive rather than a curative approach.",[77],"Diabete Type 2",[79,80],"diabete type 2","preventive approach","2022-04-05",{"date":83,"type":84},"2022-04-13","ACTUAL",{"date":86,"type":84},"2022-03-20",{"date":88,"type":71},"2028-04-01",{"name":5,"class":6},1]